EP
GOCO

Essential Partners’s GoHealth GOCO Stock Holding History

Essential Partners’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-308
Closed -$465 – 2901
2026
Q1 		$465 Buy
308
+251
+440% +$480 ﹤0.01% 2457
2025
Q4 		$123 Sell
57
-70
-55% -$239 ﹤0.01% 2518
2025
Q3 		$612 Buy
127
+118
+1,311% +$644 ﹤0.01% 2159
2025
Q2 		$50 Buy
+9
New +$71 ﹤0.01% 2149

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Essential Partners's GOCO Position: Q2 2026 in Review

Essential Partners sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 308 shares — an estimated $465 sold.

Essential Partners first reported a position in GOCO in Q2 2025 and held it in 4 quarters. The position peaked at $612 in Q3 2025. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Essential Partners reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Essential Partners sold 308 GoHealth shares in Q2 2026, an estimated $465.
  • Essential Partners first reported a position in GoHealth in Q2 2025 and held it in 4 quarters.
  • Essential Partners's GoHealth position peaked at $612 in Q3 2025.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.